ArticleJournal of pharmacy & bioallied sciences2025
Evaluation of Hypoglycemic and Hypolipidemic Effects of Jamun (Syzygium Cumini) and Paneer Flower (Withania Coagulans) and Comparison with that of Metformin in Rabbit (Oryctolagus Cuniculus): An Experimental Study.
Article in Journal of pharmacy & bioallied sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Diabetes mellitus and hyperlipidemia are the leading public health challenges worldwide, with type 2 diabetes (T2DM) representing most cases of diabetes. Traditional medicinal plants have also demonstrated efficacy in the treatment of metabolic diseases. Aim and Objectives: The present experimental study has been designed to evaluate and compare the hypoglycemic as well as hypolipidemic effects of Jamun and Paneer Flower with Metformin in rabbits for a short period. Material and Methods: Healthy non-diabetic rabbits of either sex or weighing 2-3 kg were used in this study, divided into seven groups. Animals were treated with different doses of Syzygium cumini (150 and 200 mg/kg), Withania coagulans (3 and 4 g) Methanolic extract, and Metformin group. The main endpoints centering on the monitoring of related for each participant are fasting plasma glucose, glycosylated hemoglobin (HbA1c), and serum lipid profiles. These parameters are measured by blood samples drawn at certain points during the glucose clamp. Result: Comparative Data: Analysis for the in-vivo efficacy of natural agents versus Metformin based on blood glucose and lipid levels will be assessed statistically. Conclusion: This investigation could be used to defend the potential of S. cumini and W. coagulans as complementary or adjuvant therapy among T2DM-associated hyperlipidemia that provides a natural alternative method for conventional existing treatments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.